The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2024
Filed:
Sep. 23, 2010
Applicants:
Kyungyoon Min, Kildeer, IL (US);
Katherine Radwanski, Des Plaines, IL (US);
Inventors:
Kyungyoon Min, Kildeer, IL (US);
Katherine Radwanski, Des Plaines, IL (US);
Assignee:
Fenwal, Inc., Lake Zurich, IL (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 1/02 (2006.01); A61M 1/36 (2006.01); A61M 1/02 (2006.01); A61M 1/30 (2006.01); B01D 61/28 (2006.01); B01D 61/32 (2006.01);
U.S. Cl.
CPC ...
A01N 1/0226 (2013.01); A01N 1/0273 (2013.01); A61M 1/0209 (2013.01); A61M 1/0236 (2014.02); A61M 1/30 (2013.01); A61M 1/302 (2014.02); A61M 1/303 (2014.02); A61M 1/308 (2014.02); A61M 1/3693 (2013.01); A61M 1/3696 (2014.02); B01D 61/28 (2013.01); B01D 61/32 (2013.01); A61M 1/362265 (2022.05); A61M 2202/0429 (2013.01);
Abstract
Methods and systems for processing and conditioning red blood cells are disclosed. The methods and systems may be used to make a readily transfusible red blood cell product with reduced plasma. In general, the plasma content of the supernatant of the red blood cell product is no greater than about 15%. The red blood cell products are prepared using the disclosed methods and systems remain transfusible for up to 42 days.